These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 19444620)
21. Amino acids as co-amorphous excipients for tackling the poor aqueous solubility of valsartan. Huang Y; Zhang Q; Wang JR; Lin KL; Mei X Pharm Dev Technol; 2017 Feb; 22(1):69-76. PubMed ID: 27050301 [TBL] [Abstract][Full Text] [Related]
22. Mechanism for further enhancement in drug dissolution from solid-dispersion granules upon storage. Gupta MK; Bogner RH; Goldman D; Tseng YC Pharm Dev Technol; 2002 Jan; 7(1):103-12. PubMed ID: 11852693 [TBL] [Abstract][Full Text] [Related]
23. Isolation and Physical Property Optimization of an Amorphous Drug Substance Utilizing a High Surface Area Magnesium Aluminometasilicate (Neusilin(®) US2). Allgeier MC; Piper JL; Hinds J; Yates MH; Kolodsick KJ; Meury R; Shaw B; Kulkarni MR; Remick DM J Pharm Sci; 2016 Oct; 105(10):3105-3114. PubMed ID: 27492963 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of SLS: APG mixed surfactant systems as carrier for solid dispersion. Patel AR; Joshi VY AAPS PharmSciTech; 2008; 9(2):583-90. PubMed ID: 18459049 [TBL] [Abstract][Full Text] [Related]
25. Modulating drug release profiles by lipid semi solid matrix formulations for BCS class II drug--an in vitro and an in vivo study. M K; Sistla R; Shastri NR Drug Deliv; 2015 May; 22(3):418-26. PubMed ID: 24471823 [TBL] [Abstract][Full Text] [Related]
26. Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach. Mutalik S; Anju P; Manoj K; Usha AN Int J Pharm; 2008 Feb; 350(1-2):279-90. PubMed ID: 17945447 [TBL] [Abstract][Full Text] [Related]
27. Chitosan-magnesium aluminum silicate nanocomposite films: physicochemical characterization and drug permeability. Khunawattanakul W; Puttipipatkhachorn S; Rades T; Pongjanyakul T Int J Pharm; 2010 Jun; 393(1-2):219-29. PubMed ID: 20398744 [TBL] [Abstract][Full Text] [Related]
28. Improvement in Dissolution Rate of Cefuroxime Axetil by using Poloxamer 188 and Neusilin US2. Sruti J; Patra ChN; Swain SK; Beg S; Palatasingh HR; Dinda SC; Rao ME Indian J Pharm Sci; 2013 Jan; 75(1):67-75. PubMed ID: 23901163 [TBL] [Abstract][Full Text] [Related]
29. Dissolution stability studies of suspensions of prolonged-release diclofenac microcapsules prepared by the Wurster process: I. Eudragit-based formulation and possible drug-excipient interaction. Adeyeye MC; Mwangi E; Katondo B; Jain A; Ichikawa H; Fukumori Y J Microencapsul; 2005 Jun; 22(4):333-42. PubMed ID: 16214782 [TBL] [Abstract][Full Text] [Related]
30. Preparation, characterization and in vitro dissolution studies of solid systems of valdecoxib with chitosan. Vijaya Kumar SG; Mishra DN Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1102-6. PubMed ID: 16880652 [TBL] [Abstract][Full Text] [Related]
31. Self-microemulsifying tablets prepared by direct compression for improved resveratrol delivery. Bolko Seljak K; Ilić IG; Gašperlin M; Zvonar Pobirk A Int J Pharm; 2018 Sep; 548(1):263-275. PubMed ID: 29969713 [TBL] [Abstract][Full Text] [Related]
32. Undesired co-amorphisation of indomethacin and arginine during combined storage at high humidity conditions. Petry I; Löbmann K; Grohganz H; Rades T; Leopold CS Int J Pharm; 2018 Jun; 544(1):172-180. PubMed ID: 29669257 [TBL] [Abstract][Full Text] [Related]
33. Product development studies of amino acid conjugate of Aceclofenac. Singh AP; Ramadan WM; Dahiya R; Sarpal AS; Pathak K Curr Drug Deliv; 2009 Apr; 6(2):208-16. PubMed ID: 19450228 [TBL] [Abstract][Full Text] [Related]
34. Increased dissolution rates of tranilast solid dispersions extruded with inorganic excipients. Maniruzzaman M; Ross SA; Islam MT; Scoutaris N; Nair A; Douroumis D Drug Dev Ind Pharm; 2017 Jun; 43(6):947-957. PubMed ID: 28122459 [TBL] [Abstract][Full Text] [Related]
35. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement. Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574 [TBL] [Abstract][Full Text] [Related]
36. Amelioration of tableting properties and dissolution rate of naproxen co-grinded with nicotinamide: preparation and characterization of co-grinded mixture. Khizar N; Abbas N; Ahmed M; Ahmad M; Mustafa Z; Jehangir M; Mohammed Al-Ahmary K; Hussain A; Bukhari NI; Ali I Drug Dev Ind Pharm; 2024 Jun; 50(6):537-549. PubMed ID: 38771120 [TBL] [Abstract][Full Text] [Related]
37. Glucosamine HCl as a new carrier for improved dissolution behaviour: effect of grinding. Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A Colloids Surf B Biointerfaces; 2010 Nov; 81(1):96-109. PubMed ID: 20674291 [TBL] [Abstract][Full Text] [Related]
38. Potential application of low molecular weight excipients for amorphization and dissolution enhancement of carvedilol. Pešić N; Dapčević A; Ivković B; Kachrimanis K; Mitrić M; Ibrić S; Medarević D Int J Pharm; 2021 Oct; 608():121033. PubMed ID: 34419592 [TBL] [Abstract][Full Text] [Related]
39. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone. Caron V; Tajber L; Corrigan OI; Healy AM Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367 [TBL] [Abstract][Full Text] [Related]
40. Conversion of solid dispersion prepared by acid-base interaction into free-flowing and tabletable powder by using Neusilin® US2. Shah A; Serajuddin AT Int J Pharm; 2015 Apr; 484(1-2):172-80. PubMed ID: 25724137 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]